Culture War | Will the COVID-19 Injections be Pulled Off the Market? | Guests: Dr. Peter McCullough and FDA Consumer Drug Safety Representative Kim Witczak | Why is Early Intervention STILL Not Recommended by the WHO? | Drug Safety
The Controversial Alzheimer's Drug. Aducanumab (Aduhelm™) has received accelerated approval as a treatment for Alzheimer's disease from the U.S. Food and Drug Administration (FDA).